placebo formulations. The missing amount of active substance Safinamide methanesulfonate is clinical trials

EFFECTS OF SAFINAMIDE VERSUS PLACEBO ON PAIN IN PATIENTS WITH PARKINSON’S DISEASE WITH MOTOR FLUCTUATIONS: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL. Protocol code: SAVE PAIN 2025

This study is looking at whether a drug called safinamide can help reduce pain in people with Parkinson's disease who experience 'motor fluctuations' – when their symptoms change throughout the day. It compares safinamide to a dummy pill to see if it makes a difference.